Does Immunotherapy Before Breast Cancer Surgery Offer Benefits? — Heard in the Halls: 2019 SABCS
Dr. Gianni discusses the results of the NeoTRIP trial, which looked to see if adding the immunotherapy medicine Tecentriq (chemical name: atezolizumab) to chemotherapy before surgery for triple-negative breast cancer with a high risk of recurrence could improve the time women lived without the cancer coming back.
Dr. Luca Gianni is president of the Fondazione Michelangelo in Milan, Italy.
— Last updated on June 29, 2022, 2:49 PM